Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA4 | P22748 | 5/20 | 0.78 |
| ▸ | FAHD1 | Q6P587 | 1/20 | 0.78 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | LDHA | P00338 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | CASP1 | P29466 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxalic Acid SCHEMBL193638 | 1.00 | CA4 (0.78) | CA4FAHD1MEN1LDHABLM | |
| Oxalic Acid SCHEMBL30125083 | 1.00 | CA4 (0.78) | CA4FAHD1MEN1LDHABLM | |
| Oxalic Acid SCHEMBL3865605 | 0.94 | — | — | |
| Oxalic Acid SCHEMBL29774154 | 0.94 | CA4 (0.70) | CA4FAHD1MEN1LDHABLM | |
| Oxalic Acid SCHEMBL193581 | 0.94 | CA4 (0.70) | CA4FAHD1MEN1LDHABLM | |
| Oxalic Acid SCHEMBL222911 | 0.94 | CA4 (0.89) | CA4FAHD1MEN1LDHABLM | |
| Oxalic Acid SCHEMBL9879794 | 0.94 | CA4 (0.88) | CA4FAHD1MEN1LDHABLM | |
| Oxalic Acid SCHEMBL6018199 | 0.94 | CA4 (0.88) | CA4FAHD1MEN1LDHABLM | |
| Oxalic Acid SCHEMBL50017 | 0.94 | — | — | |
| Oxalic Acid SCHEMBL10492817 | 0.89 | CA4 (0.64) | CA4FAHD1MEN1LDHABLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 139 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12616780-B2 | Medical devices containing compositions of poly(butylene succinate) and copolymers thereof | TEPHA, INC. (US) | 2026-05-05 | — | — | US | disclosed |
| US-12594361-B2 | Hernia repair, breast reconstruction and sling devices containing poly(butylene succinate) and copolymers thereof | TEPHA, INC. (US) | 2026-04-07 | — | — | US | disclosed |
| US-12570796-B2 | Polyester polymer nanocomposites | KINTRA FIBERS, INC. (US) | 2026-03-10 | — | — | US | disclosed |
| US-20260028448-A1 | BIODEGRADABLE RESIN COMPOSITION AND MOLDED BODY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2026-01-29 | — | — | US | disclosed |
| US-20250333596-A1 | POLYESTER POLYMER NANOCOMPOSITES | KINTRA FIBERS INC (US) | 2025-10-30 | — | — | US | disclosed |
| US-12428523-B2 | Polyurethanes and moisture curable compositions including the same | H.B. FULLER COMPANY (US) | 2025-09-30 | — | — | US | disclosed |
| EP-4606771-A1 | ZIRCONIA-CONTAINING ALUMINA-BASED COMPOSITE OXIDE AND METHOD FOR PRODUCING ZIRCONIA-CONTAINING ALUMINA-BASED COMPOSITE OXIDE | Daiichi Kigenso Kagaku Kogyo Co., Ltd. (JP) | 2025-08-27 | — | — | EP | disclosed |
| EP-4596603-A1 | METHOD FOR PRODUCING POLYESTER | Mitsubishi Chemical Corporation (JP) | 2025-08-06 | — | — | EP | disclosed |
| US-20250222628-A1 | METHOD FOR PRODUCING POLYESTER | MITSUBISHI CHEMICAL CORPORATION (JP) | 2025-07-10 | — | — | US | disclosed |
| CN-119968419-A | Method for producing polyester | 三菱化学株式会社 | 2025-05-09 | — | — | CN | disclosed |
| EP-2204396-A1 | Biomass-resource derived polyester and production process thereof | Mitsubishi Chemical Corporation (JP) | 2010-07-07 | — | — | EP | disclosed |
| EP-1882712-B1 | BIOMASS-RESOURCE-DERIVED POLYESTER AND PRODUCTION PROCESS THEREOF | MITSUBISHI CHEM CORP (JP) | 2010-04-21 | — | — | EP | disclosed |
| US-20090171037-A1 | a dicarboxylic acid and/or a diol derived from biomass resources; capable of suppressing hydrolysis; environmentally friendly; eco-friendly | MITSUBISHI CHEMICAL CORPORATION (JP) | 2009-07-02 | — | — | US | disclosed |
| EP-1882712-A1 | POLYESTER DERIVED FROM BIOMASS RESOURCES AND METHOD FOR PRODUCTION THEREOF | Mitsubishi Chemical Corporation (JP) | 2008-01-30 | — | — | EP | disclosed |
| US-7317069-B2 | Aliphatic polyester and process for producing the same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2008-01-08 | — | — | US | disclosed |
| US-20070093636-A1 | ALIPHATIC POLYESTER AND PROCESS FOR PRODUCING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2007-04-26 | — | — | US | disclosed |
| US-20060293492-A1 | Process for producing aliphatic polyester, a polyester produced by the process, and an aliphatic polyester | MITSUBISHI CHEMICAL CORPORATION (JP) | 2006-12-28 | — | — | US | disclosed |
| US-20060155100-A1 | Aliphatic polyester and process for producing the same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2006-07-13 | — | — | US | disclosed |
| EP-1679332-A1 | PROCESS FOR PRODUCING ALIPHATIC POLYESTER AND ALIPHATIC POLYESTER | Mitsubishi Chemical Corporation (JP) | 2006-07-12 | — | — | EP | disclosed |
| EP-1640397-A1 | ALIPHATIC POLYESTER AND PROCESS FOR PRODUCTION THEREOF | Mitsubishi Chemical Corporation (JP) | 2006-03-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12594361-B2 | Hernia repair, breast reconstruction and sling devices containing poly(butylene succinate) and copolymers thereof | LRBA, MIF, LITAF | CA4 4622/4885FAHD1 4524/4885MEN1 561/4885 |
| US-12570796-B2 | Polyester polymer nanocomposites | SORD, BECN1, DSP | CA4 552/4885FAHD1 3269/4885MEN1 4093/4885 |
| US-20260028448-A1 | BIODEGRADABLE RESIN COMPOSITION AND MOLDED BODY | SLC39A7, UROD, RER1 | CA4 1627/4885FAHD1 2221/4885MEN1 2403/4885 |
| US-12616780-B2 | Medical devices containing compositions of poly(butylene succinate) and copolymers thereof | LRBA, LDHA, CD47 | CA4 2183/4885FAHD1 4310/4885MEN1 1714/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.